Diabetes, cardiovascular disease and the microcirculation
Abstract Cardiovascular disease (CVD) is the leading cause of mortality in people with type 2 diabetes mellitus (T2DM), yet a significant proportion of the disease burden cannot be accounted for by conventional cardiovascular risk factors. Hypertension occurs in majority of people with T2DM, which i...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-04-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12933-018-0703-2 |
id |
doaj-b7abcbf2837b42b793aad816fce9a7e2 |
---|---|
record_format |
Article |
spelling |
doaj-b7abcbf2837b42b793aad816fce9a7e22020-11-24T21:45:44ZengBMCCardiovascular Diabetology1475-28402018-04-0117111010.1186/s12933-018-0703-2Diabetes, cardiovascular disease and the microcirculationW. David Strain0P. M. Paldánius1Diabetes and Vascular Medicine Research Centre, NIHR Exeter Clinical Research Facility and Institute of Biomedical and Clinical Science, University of Exeter Medical School, Royal Devon & Exeter NHS Foundation TrustNovartis Pharma AGAbstract Cardiovascular disease (CVD) is the leading cause of mortality in people with type 2 diabetes mellitus (T2DM), yet a significant proportion of the disease burden cannot be accounted for by conventional cardiovascular risk factors. Hypertension occurs in majority of people with T2DM, which is substantially more frequent than would be anticipated based on general population samples. The impact of hypertension is considerably higher in people with diabetes than it is in the general population, suggesting either an increased sensitivity to its effect or a confounding underlying aetiopathogenic mechanism of hypertension associated with CVD within diabetes. In this contribution, we aim to review the changes observed in the vascular tree in people with T2DM compared to the general population, the effects of established anti-diabetes drugs on microvascular outcomes, and explore the hypotheses to account for common causalities of the increased prevalence of CVD and hypertension in people with T2DM.http://link.springer.com/article/10.1186/s12933-018-0703-2MicrocirculationType 2 diabetes mellitusHypertensionCardiovascular diseaseMicrovascular changesMicroalbuminuria |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
W. David Strain P. M. Paldánius |
spellingShingle |
W. David Strain P. M. Paldánius Diabetes, cardiovascular disease and the microcirculation Cardiovascular Diabetology Microcirculation Type 2 diabetes mellitus Hypertension Cardiovascular disease Microvascular changes Microalbuminuria |
author_facet |
W. David Strain P. M. Paldánius |
author_sort |
W. David Strain |
title |
Diabetes, cardiovascular disease and the microcirculation |
title_short |
Diabetes, cardiovascular disease and the microcirculation |
title_full |
Diabetes, cardiovascular disease and the microcirculation |
title_fullStr |
Diabetes, cardiovascular disease and the microcirculation |
title_full_unstemmed |
Diabetes, cardiovascular disease and the microcirculation |
title_sort |
diabetes, cardiovascular disease and the microcirculation |
publisher |
BMC |
series |
Cardiovascular Diabetology |
issn |
1475-2840 |
publishDate |
2018-04-01 |
description |
Abstract Cardiovascular disease (CVD) is the leading cause of mortality in people with type 2 diabetes mellitus (T2DM), yet a significant proportion of the disease burden cannot be accounted for by conventional cardiovascular risk factors. Hypertension occurs in majority of people with T2DM, which is substantially more frequent than would be anticipated based on general population samples. The impact of hypertension is considerably higher in people with diabetes than it is in the general population, suggesting either an increased sensitivity to its effect or a confounding underlying aetiopathogenic mechanism of hypertension associated with CVD within diabetes. In this contribution, we aim to review the changes observed in the vascular tree in people with T2DM compared to the general population, the effects of established anti-diabetes drugs on microvascular outcomes, and explore the hypotheses to account for common causalities of the increased prevalence of CVD and hypertension in people with T2DM. |
topic |
Microcirculation Type 2 diabetes mellitus Hypertension Cardiovascular disease Microvascular changes Microalbuminuria |
url |
http://link.springer.com/article/10.1186/s12933-018-0703-2 |
work_keys_str_mv |
AT wdavidstrain diabetescardiovasculardiseaseandthemicrocirculation AT pmpaldanius diabetescardiovasculardiseaseandthemicrocirculation |
_version_ |
1725904568534958080 |